PT - JOURNAL ARTICLE AU - Lobascz, Brenda Czekalski AU - de França Reis, Maria Beatriz AU - e Tiburcio Mendes, Gabriella de Perez Monteiro AU - de Oliveira Cruz, Danillo Christian AU - Ferreira Damaceno, Maria Jose Caetano AU - Sartorao Filho, Carlos Izaias TI - Efficacy, Practicality, Intimal Health, and Sustainability of Menstrual Cups use among Undergraduate Medical Students: a cross-sectional study AID - 10.1101/2022.01.14.22269280 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.14.22269280 4099 - http://medrxiv.org/content/early/2022/01/14/2022.01.14.22269280.short 4100 - http://medrxiv.org/content/early/2022/01/14/2022.01.14.22269280.full AB - Introduction Women need effective, safe, and affordable menstrual hygiene products. The menstrual cup is an alternative method.Objective To identify the prevalence of menstrual cups among the medical students and the independent variables associated with their use adherence.Methods a cross-sectional study with an online survey applied to regularly matriculate women from FEMA Medical School in January 2021.Results Of 277 women, 164 participated. The mean age was 22.26 (SD 3.21). 136 preferred external pads, 60 internal pads, 28 menstrual cups, and 11 did not use. Using a 1-10 scale, price, efficacy, sustain, practice, intimal health status, hygiene, and importance of internal genitalia integrity were questioned. 37 (22,56%) women related the use of menstrual cups in the last year. Using any method to reduce menstruation had an odds ratio adjusted of 0.310 (95%CI 0.122-0.787). Concern about the environmental biodegradation had ORadj of 6.369 (95%CI 1.372-29.562); Intimal Health, ORadj of 1.996 (95%CI 1.183-3.368); internal genital integrity, ORadj of 0.824 (95%CI 0.682-0.995), for menstrual cups use.Conclusion women using a method to reduce their menstrual flow, concerning about biodegradation, concerning with intimal health, and with no concerns about manipulating their genitalia were significant independent factors for the adherence of menstrual cups.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialFEMA Ethical Committee under the number 38034920.3.0000.8547Funding StatementNo fundingsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:FEMA Ethical Committee under the number 38034920.3.0000.8547I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors